“The Immune System and MS Forum” – EASY Learning
Watch and Listen as MS Neurologists, Ben Thrower, MD and Aaron Boster, MD accurately and easily describe Multiple Sclerosis and…
Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication – FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis
Treat immediately if symptoms worsen or do not go away shortly after an injection [Posted 01/22/2025] — FDA.GOV AUDIENCE: Patient, Caregiver,…
Stuart Schlossman
Learning more about MS and Rare Autoimmune Diseases like NMOSD and MOGAD
#NMOSD #MOGAD #MS #autoimmune #raredisease…
Stuart Schlossman
Town Hall Meeting – New Frontier of Multiple Sclerosis, treatments and more
Listen and learn with Dr. Aaron Boster, MD #Sanofi #Sandoz…
Stuart Schlossman
Yes, I LIVE and BREATHE MULTIPLE SCLEROSIS
I found a way to overcome the grief of learning my condition in 1998, and turned it into a positive…
Stuart Schlossman
A LOOK at Holistic & Mainstream Approaches to Multiple Sclerosis
No excerpt…
Stuart Schlossman
Treating Multiple Sclerosis: Are They Doing It Wrong?
@AaronBosterMD Click red box to activate this video…
Stuart Schlossman
PRESS RELEASE : Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis
Paris, December 13, 2024. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of…
Stuart Schlossman
Gabapentinoids, yet another dirty secret
Some people with MS are on ten or more concomitant medications including gabapentin or pregabalin. Are you? Gavin Giovannoni –…
Stuart Schlossman
Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms
September 19, 2024 – Meaningful characterization is critical to advancing research and care, review authors contend The currently used phenotypic…
Stuart Schlossman
